Considerations for the Assessment of Substrates, Genetics and Risk Factors in Patients with Atrial Fibrillation
Main Authors: | Dominik Linz, Sander Verheule, Aaron Isaacs, Ulrich Schotten |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2021-10-01
|
Series: | Arrhythmia & Electrophysiology Review |
Online Access: | https://www.aerjournal.com/articleindex/aer.2020.51 |
Similar Items
-
ATRIAL SOURCES OF REACTIVE OXYGEN SPECIES VARY WITH THE SUBSTRATE AND DURATION OF ATRIAL FIBRILLATION: IMPLICATIONS FOR THE ANTIARRHYTHMIC EFFECT OF STATINS
by: Reilly, S, et al.
Published: (2011) -
Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins
by: Reilly, S, et al.
Published: (2011) -
Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.
by: Reilly, S, et al.
Published: (2011) -
Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins.
by: Reilly, SN, et al.
Published: (2011) -
Central sleep apnea in atrial fibrillation: Risk factor or marker of untreated underlying disease?
by: Dominik Linz, et al.
Published: (2020-10-01)